Targeting Generation of Antibodies Specific to Conformational Epitopes of Amyloid β-Derived Neurotoxins
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
8
Page:
65-81
Author(s):
Mary P. Lambert, Pauline T. Velasco, Kirsten L. Viola and William L. Klein
Multivalent & Multifunctional Ligands to β-Amyloid
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
637-658
Author(s):
YoungSoo Kim, Ji Hoon Lee, Jiyeon Ryu and Dong Jin Kim
Humanin; A Defender Against Alzheimers Disease?
Journal:
Recent Patents on CNS Drug Discovery (Discontinued)
Volume:
4
Page:
37-42
Author(s):
Masaaki Matsuoka
Kawasakis Disease, Acrodynia, and Mercury
Journal:
Current Medicinal Chemistry
Volume:
15
Page:
3000-3010
Author(s):
J. Mutter and D. Yeter
New Proposals for Treatment Sporadic Alzheimers Disease
Journal:
Central Nervous System Agents in Medicinal Chemistry
Volume:
8
Page:
286-296
Author(s):
Ryszard Pluta and Marzena Ulamek
Intracellular Amyloid β-Protein As a Therapeutic Target for Treating Alzheimers Disease
Journal:
Current Alzheimer Research
Volume:
5
Page:
555-561
Author(s):
Y. Ohyagi
Amyloid-Targeted Metal Chelation, Anti-Oxidative Stress, and Anti- Inflammation as Potential Alzheimers Therapies
Journal:
Current Bioactive Compounds
Volume:
4
Page:
140-149
Author(s):
A. Fydrych, R. D. Moir, C. Huang, Y. Shi, J. T. Rogers and X. Huang
Pathogenesis of and Therapeutic Strategies to Ameliorate the Transthyretin Amyloidoses
Journal:
Current Pharmaceutical Design
Volume:
14
Page:
3219-3230
Author(s):
Yoshiki Sekijima, Jeffery W. Kelly and Shu-ichi Ikeda
Amyloid β -Protein Assembly as a Therapeutic Target of Alzheimers Disease
Journal:
Current Pharmaceutical Design
Volume:
14
Page:
3231-3246
Author(s):
Ghiam Yamin, Kenjiro Ono, Mohammed Inayathullah and David B. Teplow
Biochemical Markers in CSF of ALS Patients
Journal:
Current Medicinal Chemistry
Volume:
15
Page:
1788-1801
Author(s):
Sigurd D. Sussmuth, Johannes Brettschneider, Albert C. Ludolph and Hayrettin Tumani